Previous close | 9.30 |
Open | 9.30 |
Bid | 0.00 |
Ask | 0.00 |
Strike | 100.00 |
Expiry date | 2023-04-21 |
Day's range | 9.30 - 9.30 |
Contract range | N/A |
Volume | |
Open interest | N/A |
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Novartis (NVS) Kisqali meets primary endpoint of invasive disease-free survival in certain patients with early breast cancer at risk of recurrence.
Pharming Group (PHAR) obtains FDA approval for leniolisib for the treatment of a rare pediatric disease. The stock of the company is up about 33% following the same.